Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 16, 2024 (filed on Apr 18, 2024)Insider Name:Hoffman WilliamOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,451Price:$40.00
-
Apr 12, 2024 (filed on Apr 16, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Stock Options (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-6,000Price:--
-
Apr 12, 2024 (filed on Apr 16, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-6,000Price:$40.96
-
Apr 12, 2024 (filed on Apr 16, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:6,000Price:$0.46
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,292Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,475Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-947Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-508Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-458Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-662Price:--
Filings by filing date
-
Apr 16, 2024 (filed on Apr 18, 2024)Insider Name:Hoffman WilliamOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,451Price:$40.00
-
Apr 12, 2024 (filed on Apr 16, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Stock Options (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-6,000Price:--
-
Apr 12, 2024 (filed on Apr 16, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-6,000Price:$40.96
-
Apr 12, 2024 (filed on Apr 16, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:6,000Price:$0.46
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,292Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,475Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-947Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hykes AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-508Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-458Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hill, Mitch C.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-662Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 6001 Oak Canyon, Suite 100 IRVINE CA 92618 |
Tel: | N/A |
Website: | https://www.inarimedical.com |
IR: | See website |
Key People | ||
Andrew Hykes President, Chief Executive Officer, Director | Mitchell C. Hill Chief Financial Officer | Thomas Tu Chief Medical Officer |
Business Overview |
Inari Medical, Inc. is a medical device company. The Company's products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. |
Financial Overview |
For the fiscal year ended 31 December 2023, Inari Medical Inc revenues increased 29% to $493.6M. Net loss decreased 94% to $1.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Interest Income increase from $1.9M to $15.6M (income), Interest Expense decrease of 33% to $196K (expense). |
Employees: | 1,300 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $2,091M as of Dec 31, 2023 |
Annual revenue (TTM): | $493.63M as of Dec 31, 2023 |
EBITDA (TTM): | -$7.14M as of Dec 31, 2023 |
Net annual income (TTM): | -$1.64M as of Dec 31, 2023 |
Free cash flow (TTM): | $29.73M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 57,960,555 as of Feb 23, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |